Skip to main content

Share story

Infrastructure Products

BMW automates daily cost-anomaly checks across 14,000 cloud accounts

BMW automates daily cost-anomaly checks across 14,000 cloud accounts Image: Primary
BMW Group says its Cloud Efficiency Analytics system now checks more than 14,000 cloud accounts daily and emails owners when spending departs from expected patterns. The system aggregates roughly 3 billion monthly billing rows, trains forecasts on 365 days of history and processes the estate in about 20 minutes using as many as 500 concurrent functions. Alerts require both statistical deviation and minimum financial impact, with higher thresholds for volatile services. The compute costs about $50 per month, but the detector cannot determine whether a spending increase was intentional and is strongest at identifying spikes rather than sustained changes.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from AWS Machine Learning Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...